The store will not work correctly when cookies are disabled.
5-(3,4-Dimethoxy-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline
ID: ALA312567
PubChem CID: 10063751
Max Phase: Preclinical
Molecular Formula: C19H18N2O2
Molecular Weight: 306.37
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(C2=Cc3ccccc3C3=NCCN23)cc1OC
Standard InChI: InChI=1S/C19H18N2O2/c1-22-17-8-7-14(12-18(17)23-2)16-11-13-5-3-4-6-15(13)19-20-9-10-21(16)19/h3-8,11-12H,9-10H2,1-2H3
Standard InChI Key: MBOMVGGFKXGWMJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
5.4250 -4.0167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9125 -4.3167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4542 -3.4375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9417 -3.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3917 -4.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0542 -3.4375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9125 -4.9250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4125 -3.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3542 -3.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9542 -3.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2500 -3.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3500 -2.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9417 -2.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9417 -4.3167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9417 -4.9250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1042 -4.5292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.8500 -3.4292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8625 -4.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9000 -3.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6875 -4.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1500 -3.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3500 -3.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3667 -3.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 3 2 0
5 2 1 0
6 3 1 0
7 2 2 0
8 4 1 0
9 6 2 0
10 9 1 0
11 13 1 0
12 6 1 0
13 12 2 0
14 1 1 0
15 14 1 0
16 10 1 0
17 11 1 0
18 5 1 0
19 8 1 0
20 16 1 0
21 17 1 0
22 18 2 0
23 19 2 0
15 7 1 0
8 5 2 0
11 10 2 0
22 23 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 306.37 | Molecular Weight (Monoisotopic): 306.1368 | AlogP: 3.28 | #Rotatable Bonds: 3 |
Polar Surface Area: 34.06 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.15 | CX LogP: 2.74 | CX LogD: 2.55 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.87 | Np Likeness Score: -0.08 |
References
1. Houlihan WJ, Munder PG, Handley DA, Cheon SH, Parrino VA.. (1995) Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines., 38 (2): [PMID:7830265] [10.1021/jm00002a004] |